Quarter Financials
Aeglea BioTherapeutics, Inc. (AGLE)
$11.66
-0.59 (-4.82%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Net Income | -217 | -18 | -19 | -18 | -22 | -24 | -20 | -20 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -661 | -444 | -426 | -407 | -389 | -366 | -342 | -321 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Capital Expenditure | - | - | - | -0 | - | -0 | - | -0 |
|---|
| Net PPE | 2 | 7 | 7 | 7 | 8 | 8 | 8 | 9 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| New Purchases | -26 | -13 | -4 | -24 | -7 | -5 | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|